A pharmaceutical composition for treating or preventing a papillomavirus
infection or tumour, including, as the therapeutical agents, a
polypeptide from an early region and a polypeptide from a late region of
a papillomavirus, optionally combined with a polypeptide having
immunostimulatory activity or a polypeptide from an early or late region
of a papillomavirus and a polypeptide having immunostimulatory activity,
or alternatively, a recombinant vector containing inserted DNA fragments
coding for the above-mentioned polypeptide combinations.
